Goldman Sachs Double Downgrades Best Buy to Sell, Cuts Price Target to $59
Goldman Sachs cut Best Buy to Sell, citing rising costs, weak demand, and slower growth hurting future sales and profits.
NOTRELOAD AI
Nike Shakes Up Innovation Team Again as Stock Hits 10-Year Low
Nike innovation chief leaves after less than a year amid falling sales, China struggles, and faster rivals; company reshuffles leadership.
Commvault Explores Sale After Takeover Interest from Thoma Bravo
Commvault may be sold as buyers show interest. Stock down on AI fears but revenue growing; Thoma Bravo among potential bidders.
FDA Rejects Replimune’s Skin Cancer Drug for the Second Time
FDA again rejects Replimune’s skin cancer drug RP1, saying studies don’t prove it works; shares halted, setback for company.
FDA Accepts Telix Pixclara NDA: Brain Cancer Imaging Tool on Track for September 2026 Decision
Telix’s Pixclara brain cancer scan got FDA review accepted. It helps detect tumors vs treatment effects. Decision due 2026.
TSMC Reports 35% Revenue Surge as AI Demand Stays Strong Despite Middle East War
TSMC sales jumped 35% as AI chip demand stays strong, easing fears of Middle East tensions slowing tech growth.